Insider Transactions in Q1 2023 at Sesen Bio, Inc. (SESN)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 07
2023
|
Chidozie Ugwumba Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,215,877
+50.0%
|
-
|
Mar 07
2023
|
Michael Torok Director |
BUY
Grant, award, or other acquisition
|
Indirect |
369,991
+50.0%
|
-
|
Mar 07
2023
|
Michael Torok Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,250
+50.0%
|
-
|
Mar 07
2023
|
Michael Klichinsky Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
484,347
+50.0%
|
-
|
Mar 07
2023
|
Regina Hodits Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,297,546
+50.0%
|
-
|
Mar 07
2023
|
Briggs Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,175
+50.0%
|
-
|
Mar 07
2023
|
Sanford S Zweifach Director |
BUY
Grant, award, or other acquisition
|
Direct |
413
+50.0%
|
-
|
Mar 02
2023
|
Elly Ryu Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
17,289
-10.42%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Glen C Mac Donald Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
170,372
-16.74%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Glen C Mac Donald Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
286,292
+25.6%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Mark Sullivan General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
219,218
-21.14%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Mark Sullivan General Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
298,175
+26.81%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Monica Forbes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
345,849
-22.15%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Monica Forbes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
371,125
+24.98%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Thomas R Cannell President and CEO |
SELL
Open market or private sale
|
Direct |
487,487
-33.53%
|
$0
$0.59 P/Share
|
Mar 02
2023
|
Thomas R Cannell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
606,800
+38.95%
|
$0
$0.59 P/Share
|
Feb 21
2023
|
Thomas R Cannell President and CEO |
SELL
Open market or private sale
|
Direct |
53,727
-8.85%
|
$0
$0.59 P/Share
|
Feb 21
2023
|
Elly Ryu Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,159
-4.14%
|
$0
$0.59 P/Share
|
Feb 21
2023
|
Mark Sullivan General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
39,831
-11.73%
|
$0
$0.59 P/Share
|
Feb 21
2023
|
Glen C Mac Donald Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
25,927
-8.39%
|
$0
$0.59 P/Share
|
Feb 21
2023
|
Monica Forbes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
61,862
-11.41%
|
$0
$0.59 P/Share
|